東陽光藥 06887Prospectus Information

Prospectus Information
IPO Timeline
Broker Results (T-2)
2025-08-05
Some brokers release in afternoon
Grey Market (T-1)
2025-08-06
Afternoon
HKEX Allotment (T-1)
2025-08-06
Evening
Registrar Allotment (T-1)
2025-08-06
Evening
Listing Day (T)
2025-08-07
First day of trading
Company Overview
Stock Name東陽光藥
Stock Code06887
Company Full Name東陽光藥
IndustryHealthcare
Principal Activities一家綜合性製藥公司,從事藥物的研發、生產和商業化,專注於感染、慢病及腫瘤等治療領域。
Listing Date2025-08-07
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國廣東省東莞市松山湖園區工業北路1號
Business Address (Hong Kong)香港灣仔皇后大道東248號大新金融中心40樓
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehecpharm.com
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact卓佳证券登记有限公司,香港金钟道89号力宝中心1座31楼3101-3103室
A-Share/US Dual ListingNo
Offering Information
Offering Mechanism To be extracted
Offer PriceTo be extracted
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueRMB 1.0 / shares
Offer PeriodTo be extracted
Global Offering SharesTo be extracted
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPO576,656,047 shares
Greenshoe (Over-allotment Option)No
Stabilizing Manager (Greenshoe)
Cornerstone Share0%
Clawback TiersTo be extracted
Reallocation OptionNo
Total Global Offering SizeTo be extracted
Valuation & Financials
Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)To be extracted
P/E Ratio不适用(公司处于亏损状态)
Profit/Loss Status盈利约人民币24.8百万元
Period-End Cash Balance人民币1,920,200,000元
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted
First Day Performance
First Day CloseLoading...
Underwriting Syndicate
Sponsor
中國國際金融香港證券有限公司
Reporting Accountant
畢馬威會計師事務所
Property Valuer
不適用
Cornerstone Investors
No data
Directors & Management
Chairman張英俊
Company Secretary鄭程傑
No director data available.
Major Shareholders
Major Shareholders & Holdings控股股東為張先生、郭女士、廣東東陽光科技等一組股東,緊隨上市後直接或間接控制本公司50.98%的投票權。
IPO Timeline
Disclaimer & Risk Warning

Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.

Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.

Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.

Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.

Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.

Cibo — IPO & Market Data Analytics